Allogeneic transplantation for CML in the TKI era: striking the right balance
File(s)
Accepted version
Author(s)
Innes, AJ
Milojkovic, D
Apperley, JF
Type
Journal Article
Date Issued
2016-02-01
ISSN
1759-4774
Publisher
NATURE PUBLISHING GROUP
Start Page
79
End Page
91
Journal / Book Title
NATURE REVIEWS CLINICAL ONCOLOGY
Volume
13
Issue
2
Copyright Statement
Copyright © 2015, Rights Managed by Nature Publishing Group
Sponsor
Imperial College Trust
Leuka
Leuka
National Institute for Health Research
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369034300007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Grant Number
070904JA
na
Renew P45896 Core Grant 2014
NF-SI-0611-10275
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
CHRONIC MYELOID-LEUKEMIA
STEM-CELL TRANSPLANTATION
CHRONIC MYELOGENOUS LEUKEMIA
TYROSINE KINASE INHIBITORS
BONE-MARROW-TRANSPLANTATION
VERSUS-HOST-DISEASE
CHRONIC GRANULOCYTIC-LEUKEMIA
ACUTE LYMPHOBLASTIC-LEUKEMIA
CORD BLOOD TRANSPLANTATION
BCR-ABL TRANSCRIPTS
Chemotherapy, Adjuvant
Hematopoietic Stem Cell Transplantation
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Transplantation Conditioning
Transplantation, Homologous
Publication Status
Published